<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04896242</url>
  </required_header>
  <id_info>
    <org_study_id>11190071</org_study_id>
    <nct_id>NCT04896242</nct_id>
  </id_info>
  <brief_title>Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients</brief_title>
  <official_title>Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate and compare the changes by two modalities: Imaging&#xD;
      by Strain by Speckle Tracking and Magnetic Resonance versus soluble markers of cardiac&#xD;
      dysfunction as early predictors of cardio-toxicity in cancer patients receiving low or high&#xD;
      doses of radiotherapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Global Longitudinal Strain (Left Ventricle)</measure>
    <time_frame>Baseline, 1 and 12 weeks after Treatment</time_frame>
    <description>&gt;5 Absolute drop or 12% Relative reduction from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac Magnetic Resonance Cinema Imaging</measure>
    <time_frame>Baseline, 1 and 12 weeks after treatment</time_frame>
    <description>Cinema imaging: Long axis balance, Balance 4 cameras, Short shaft full balance, Right ventricular balance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Magnetic Resonance Anatomical Image</measure>
    <time_frame>Baseline, 1 and 12 weeks after treatment</time_frame>
    <description>Inversion recovery single shot balance 3D short axis covering the entire heart and aorta with free respiratory trigger</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Magnetic Resonance Flow Image</measure>
    <time_frame>Baseline, 1 and 12 weeks after treatment</time_frame>
    <description>2D outflow tract of the aorta 2D pulmonary artery outflow tract</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Magnetic Resonance Quantitative Image</measure>
    <time_frame>Baseline, 1 and 12 weeks after treatment</time_frame>
    <description>T1 map short axis apical section T1 map short axis medial section T1 map short axis basal section&#xD;
T2 map short axis apical section T2 map short axis medial section T2 map short axis basal section</description>
  </secondary_outcome>
  <other_outcome>
    <measure>High-sensitivity Cardiac Troponin-T</measure>
    <time_frame>Baseline, 1 and 12 weeks after treatment</time_frame>
    <description>Troponin rises &gt;99%th percentile of the upper reference limit</description>
  </other_outcome>
  <other_outcome>
    <measure>N-Terminal pro-Brain Natriuretic Peptide</measure>
    <time_frame>Baseline, 1 and 12 weeks after treatment</time_frame>
    <description>N-Terminal pro-Brain Natriuretic Peptide, rises &gt;99%th percentile of the upper reference limit</description>
  </other_outcome>
  <other_outcome>
    <measure>Circulating Endothelial Cells</measure>
    <time_frame>Baseline, 1 and 12 weeks after treatment</time_frame>
    <description>Number of Circulating Endothelial Cells</description>
  </other_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Radiotherapy; Complications</condition>
  <condition>Cardiotoxicity</condition>
  <condition>Cancer</condition>
  <condition>Lung Cancer</condition>
  <condition>Breast Cancer</condition>
  <condition>Esophageal Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cancer of the thoracic area (lung, breast, esophagus or other thoracic&#xD;
        locations) that will receive curative radiotherapy to the thoracic region at Pontificia&#xD;
        Universidad Católica de Chile.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥18 year-old patients&#xD;
&#xD;
          -  With histologically confirmed thoracic cancer (breast, esophagus or lung)&#xD;
&#xD;
          -  Recommendation of thoracic radiotherapy (RT) with curative intent&#xD;
&#xD;
          -  With or without chemotherapy&#xD;
&#xD;
          -  All patients must be able to read and understand Spanish&#xD;
&#xD;
          -  All patients must sign informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with no medical records,&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Previously diagnosed with severe left ventricular dysfunction or a cardiac&#xD;
             insufficiency&#xD;
&#xD;
          -  Patients with metastatic disease and indication of palliative RT&#xD;
&#xD;
          -  Patients with significant comorbidities associated to a &lt;5 year life expectancy.&#xD;
&#xD;
          -  Patients previously treated with thoracic RT&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomas Merino Lara</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tomas M Merino, MD</last_name>
    <phone>+5622352000</phone>
    <phone_ext>6832</phone_ext>
    <email>tmerino@med.puc.cl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pontificia Universidad Catolica de Chile</name>
      <address>
        <city>Santiago</city>
        <state>Metropolitana</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomas Merino, MD</last_name>
      <phone>+5623542000</phone>
      <phone_ext>6832</phone_ext>
    </contact>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 9, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiotoxicity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

